Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults

NCT ID: NCT07217951

Last Updated: 2025-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-31

Study Completion Date

2028-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current health devices often overlook older users, who may face both health challenges and technology barriers. We are investigating the feasibility of wearable sensors to track posture, heart rate, and breathing, alongside a microneedle patch that collect body fluids to measure stress and inflammation markers. By combining this data, we aim to create an easy to use system that supports personalized, at home health monitoring for older adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Devices capable of measuring, interpreting, and providing guidance based on a range of biosignals have significantly broadened the access to health information. Nevertheless, the majority of these platforms are designed for a demographic already proficient in technology, thereby excluding older adults, a group facing unique health challenges and often experiencing technological apprehension. To address this disparity, this study aims to demonstrate the feasibility of employing a wearable eutectogel-sensor patch system to monitor and analyze posture, movement, heart rate, and respiration of older adults within their natural living environments. Furthermore, investigators seek to develop algorithms that correlate these real-time data streams with physical and cognitive performance outcomes. Concurrently, they will investigate the feasibility of employing hydrogel microneedle patches for the passive collection of interstitial fluid (ISF) to measure key biomarkers associated with stress and inflammation, specifically cortisol, dopamine, and C-reactive protein (CRP). These biomarkers serve as critical indicators of physiological stress, mood regulation, and systemic inflammation, which are closely associated with cognitive decline, frailty, and diminished quality of life in the aging population. Eutectogel sensor patches are flexible, breathable, inconspicuous, and designed for long-term wear. They can be positioned strategically to provide direct, continuous, real-time monitoring of posture, motion, heart rate, and respiration. We now propose to determine the feasibility of using a eutectogel sensor patch system to continuously collect posture, motion, heart rate, and respiration data in free-living older adults. Investigators will secondly assess the feasibility of measuring dopamine, cortisol, and CRP from ISF collected with a microneedle patch and correlate them with the same analytes measured in saliva. These analytes were selected due to their relevance in detecting chronic stress and systemic inflammation-conditions that are highly prevalent and often underdiagnosed in the aging population. The research objectives are significant because they aim to bridge the technological and demographic gap through a combined sensing system that enables seamless and meaningful health monitoring in real-world settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Stress Systemic Inflammation Mobility and Independence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Older adults

Adults aged 65 or older

Eutectogel Sensors and Microneedle Patches

Intervention Type DEVICE

Eutectogel Sensors:

While the exact eutectogel formulation in this study has not been previously tested in humans, similar eutectogel-based materials have been employed in wearable biosensing devices with human participants. These systems are typically composed of biocompatible matrices such as gelatin or polyacrylamide combined with deep eutectic solvents (DES) to improve ionic conductivity and flexibility.

Microneedle Patches:

The microneedle patch in this study is composed of poly(acrylic acid)/gelatin methacryloyl (PAA/GelMA), gelatin/oxidized pectin (Gelatin/OxP), and methacrylated hyaluronic acid/maleic anhydride (MeHA/MA). Although the integrated use of these specific compositions has not yet been evaluated in humans, the materials themselves, as well as similar microneedle architectures, have been thoroughly investigated in vivo and even in clinical trials.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eutectogel Sensors and Microneedle Patches

Eutectogel Sensors:

While the exact eutectogel formulation in this study has not been previously tested in humans, similar eutectogel-based materials have been employed in wearable biosensing devices with human participants. These systems are typically composed of biocompatible matrices such as gelatin or polyacrylamide combined with deep eutectic solvents (DES) to improve ionic conductivity and flexibility.

Microneedle Patches:

The microneedle patch in this study is composed of poly(acrylic acid)/gelatin methacryloyl (PAA/GelMA), gelatin/oxidized pectin (Gelatin/OxP), and methacrylated hyaluronic acid/maleic anhydride (MeHA/MA). Although the integrated use of these specific compositions has not yet been evaluated in humans, the materials themselves, as well as similar microneedle architectures, have been thoroughly investigated in vivo and even in clinical trials.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 65 or older
2. Expressed willingness to participate.
3. Able to give written informed consent
4. Able to operate a smartphone and complete surveys

Exclusion Criteria

1. Reliance on assistive walking devices
2. Inability to operate a smartphone
3. Unable to complete surveys
4. Unable to give written informed consent
5. Younger than 65 years old
6. Known skin allergies to kinesiology tape (KT tape)
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

Tufts University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sameer Sonkusale, PhD

Role: PRINCIPAL_INVESTIGATOR

Tufts University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jean Mayer USDA Human Nutrition Research Center on Aging

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kyla Shea, PhD

Role: CONTACT

16175563370

Emilie Buisson, MS

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x.

Reference Type BACKGROUND
PMID: 15817019 (View on PubMed)

Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci. 2023 Jun 29;15(1):27. doi: 10.1038/s41368-023-00231-6.

Reference Type BACKGROUND
PMID: 37386003 (View on PubMed)

Wu Z, Qiao Z, Chen S, et al. Interstitial fluid-based wearable biosensors for minimally invasive healthcare and biomedical applications. Communications Materials. 2024;5(1):33. 10.1038/s43246-024-00468-6,

Reference Type BACKGROUND

Cheng KC, Aeron S, Hughes MC, Miller EL. Nonparametric and Regularized Dynamical Wasserstein Barycenters for Sequential Observations. IEEE Transactions on Signal Processing. 2022;71:3164-3178.

Reference Type BACKGROUND

Cheng K, Aeron S, Hughes MC, Miller EL. Dynamical Wasserstein barycenters for time-series modeling. Advances in Neural Information Processing Systems. 2021;34:27991-28003

Reference Type BACKGROUND

Zhang H, Miller EL, Abriola LM. Manifold regression for subsurface contaminant characterization based on sparse concentration data. Paper presented at: 2014 IEEE Geoscience and Remote Sensing Symposium; 13-18 July 2014, 2014.

Reference Type BACKGROUND

Bhattarai KR, Kim HR, Chae HJ. Compliance with Saliva Collection Protocol in Healthy Volunteers: Strategies for Managing Risk and Errors. Int J Med Sci. 2018 May 22;15(8):823-831. doi: 10.7150/ijms.25146. eCollection 2018.

Reference Type BACKGROUND
PMID: 30008593 (View on PubMed)

Gupta S, Nayak MT, Sunitha JD, Dawar G, Sinha N, Rallan NS. Correlation of salivary glucose level with blood glucose level in diabetes mellitus. J Oral Maxillofac Pathol. 2017 Sep-Dec;21(3):334-339. doi: 10.4103/jomfp.JOMFP_222_15.

Reference Type BACKGROUND
PMID: 29391704 (View on PubMed)

Iijima H, Shimoura K, Eguchi R, Aoyama T, Takahashi M. Concurrent validity and measurement error of stair climb test in people with pre-radiographic to mild knee osteoarthritis. Gait Posture. 2019 Feb;68:335-339. doi: 10.1016/j.gaitpost.2018.12.014. Epub 2018 Dec 10.

Reference Type BACKGROUND
PMID: 30576977 (View on PubMed)

Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.

Reference Type BACKGROUND
PMID: 10380242 (View on PubMed)

Gelatin Food additive and GRAS regulations. U.S. Food and Drug Administration; 2025.

Reference Type BACKGROUND

184.1724 Sodium Alginate. Code of Federal Regulations Title 21.

Reference Type BACKGROUND

CELLULOSE, MICROCRYSTALLINE. U.S. Food and Drug Administration; 2025

Reference Type BACKGROUND

Master H, Coleman G, Dobson F, Bennell K, Hinman RS, Jakiela JT, White DK. A Narrative Review on Measurement Properties of Fixed-distance Walk Tests Up to 40 Meters for Adults With Knee Osteoarthritis. J Rheumatol. 2021 May;48(5):638-647. doi: 10.3899/jrheum.200771. Epub 2020 Oct 15.

Reference Type BACKGROUND
PMID: 33060316 (View on PubMed)

182.1320 Glycerin. Code of Federal Regulations Title 21, Environmental Protection Agency; 2025

Reference Type BACKGROUND

Zhang J, Li H, Albakr L, Zhang Y, Lu A, Chen W, Shao T, Zhu L, Yuan H, Yang G, Wheate NJ, Kang L, Wu C. Microneedle-enabled therapeutics delivery and biosensing in clinical trials. J Control Release. 2023 Aug;360:687-704. doi: 10.1016/j.jconrel.2023.07.023. Epub 2023 Jul 19.

Reference Type BACKGROUND
PMID: 37442203 (View on PubMed)

Zhu J, Zhou X, Kim HJ, et al. Gelatin Methacryloyl Microneedle Patches for Minimally Invasive Extraction of Skin Interstitial Fluid. Small. 2020;16(16):e1905910. PMC7182487. 9. Chang H, Zheng M, Yu X, et al. A Swellable Microneedle Patch to Rapidly Extract Skin Interstitial Fluid for Timely Metabolic Analysis. Adv Mater. 2017;29(37). 10.1002/adma.201702243

Reference Type BACKGROUND

Long W, George Joy J, Lee SJ, Kim JC. Collagen- and Hyaluronic Acid-Based Microneedles With Thiolated Pectin for Redox-Responsive Drug Delivery. J Biomed Mater Res A. 2025 Apr;113(4):e37903. doi: 10.1002/jbm.a.37903.

Reference Type BACKGROUND
PMID: 40156176 (View on PubMed)

Shu Y, Qi Y, Zou Y, Huang Y, Chen J, Li J, Chen L, Zhu X. A gelatin microneedles featuring antibacterial and reactive oxygen species scavenging properties for treating Vibrio vulnificus-infected wounds. Int J Biol Macromol. 2025 May;309(Pt 1):142640. doi: 10.1016/j.ijbiomac.2025.142640. Epub 2025 Mar 28.

Reference Type BACKGROUND
PMID: 40158599 (View on PubMed)

Liu D, Wang S, Wang H, Zhang Z, Wang H. A flexible, stretchable and wearable strain sensor based on physical eutectogels for deep learning-assisted motion identification. J Mater Chem B. 2024 Jun 27;12(25):6102-6116. doi: 10.1039/d4tb00809j.

Reference Type BACKGROUND
PMID: 38836422 (View on PubMed)

Lu Q, Li H, Tan Z. Zwitterionic Eutectogel-Based Wearable Strain Sensor with Superior Stretchability, Self-Healing, Self-Adhesion, and Wide Temperature Tolerance. ACS Appl Mater Interfaces. 2023 Jul 19;15(28):34055-34063. doi: 10.1021/acsami.3c05848. Epub 2023 Jul 6.

Reference Type BACKGROUND
PMID: 37410953 (View on PubMed)

Wang Y, Zhou W, Shen C, Jiang G, Yang C. Flexible and printable integrated biosensors for monitoring sweat and skin condition. Anal Biochem. 2023 Jan 15;661:114985. doi: 10.1016/j.ab.2022.114985. Epub 2022 Nov 19.

Reference Type BACKGROUND
PMID: 36414087 (View on PubMed)

Qin H, Owyeung RE, Sonkusale SR, Panzer MJ. Highly stretchable and nonvolatile gelatin-supported deep eutectic solvent gel electrolyte-based ionic skins for strain and pressure sensing. Journal of Materials Chemistry C. 2019;7(3):601-608. 10.1039/C8TC05918G

Reference Type BACKGROUND

Wei Z, Jia L, Yu J, Xu H, Guo X, Xiang T, Zhou S. Environmentally tolerant multifunctional eutectogel for highly sensitive wearable sensors. Mater Horiz. 2025 Apr 14;12(8):2604-2618. doi: 10.1039/d4mh01665c.

Reference Type BACKGROUND
PMID: 39806946 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AG091766

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01AG091766

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.